A photo of David Haslam.

David B. Haslam, MD

  • Director, Antimicrobial Stewardship Program
  • Director, Microbial Genomics and Metagenomics Laboratory
  • Professor, UC Department of Pediatrics
I work with my patients and their families as a team and feel that taking care of children is a wonderful privilege and a responsibility.

About

Biography

I was influenced by my father, who was a pediatrician and took great satisfaction in caring for children. As a pediatric infectious disease specialist, I work with my patients and their families as a team and feel that taking care of children is a wonderful privilege and a responsibility.

In my practice, I try to be flexible by coordinating my patients’ appointments with those of other providers when possible. I’m committed to providing continuity and to being accessible between visits.

I’m the director of the Antimicrobial Stewardship Program and the Microbial Genomics and Metagenomics Laboratory. I've received several teaching and research awards, including the Pediatric Infectious Disease Society Young Investigator Award.

The main focus of my research is on the microbiome, which is the community of bacteria, viruses, fungi and other organisms that live on the human body. The goal is to understand how the microbiome influences disease and contributes to health in children. A healthy microbiome helps protect against infection, allergy, gastrointestinal diseases, heart disease, diabetes and diseases of premature infants.

In my free time, I enjoy riding my bike.

MD: University of Calgary, Calgary, Alberta.

Rotating Internship: McGill University, Montreal, Quebec.

Residency: University of Ottawa, Ottawa, Quebec.

Fellowship: Washington University School of Medicine, St. Louis, MO.

Services and Specialties

Infectious Diseases, Autoimmune Liver Disease

Research Areas

Infectious Diseases

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease. Hellmann, J; Ta, A; Ollberding, NJ; Bezold, R; Lake, K; Jackson, K; Dirksing, K; Bonkowski, E; Haslam, DB; Denson, LA. Inflammatory Bowel Diseases. 2022.

Friendly fungi: symbiosis with commensal Candida albicans. Shao, T; Haslam, DB; Bennett, RJ; Way, SS. Trends in Immunology. 2022.

Candida albicans oscillating UME6 expression during intestinal colonization primes systemic Th17 protective immunity. Shao, TY; Kakade, P; Witchley, JN; Frazer, C; Murray, KL; Ene, IV; Haslam, DB; Hagan, T; Noble, SM; Bennett, RJ; et al. Cell Reports. 2022; 39.

Aligning Provider Prescribing With Guidelines for Soft Tissue Infections. Kovaleski, C; Courter, JD; Ghulam, E; Hagedorn, PA; Haslam, DB; Kurowski, EM; Rudloff, J; Szczesniak, R; Dexheimer, JW. Pediatric Emergency Care. 2022; 38:e1063-e1068.

Lethal Pediatric Cerebral Vasculitis Triggered by Severe Acute Respiratory Syndrome Coronavirus 2. Poisson, KE; Zygmunt, A; Leino, D; Fuller, CE; Jones, BV; Haslam, D; Staat, MA; Clay, G; Ting, TV; Wesselkamper, K; et al. Pediatric Neurology. 2022; 127:1-5.

A unique gut microbiota signature in pulmonary arterial hypertension: A pilot study. Jose, A; Apewokin, S; Hussein, WE; Ollberding, NJ; Elwing, JM; Haslam, DB. Pulmonary Circulation. 2022; 12.

Future Applications of Metagenomic Next-Generation Sequencing for Infectious Diseases Diagnostics. Haslam, DB. Journal of the Pediatric Infectious Diseases Society. 2021; 10:S112-S117.

Commensal segmented filamentous bacteria-derived retinoic acid primes host defense to intestinal infection. Woo, V; Eshleman, EM; Hashimoto-Hill, S; Whitt, J; Wu, SE; Engleman, L; Rice, T; Karns, R; Qualls, JE; Haslam, DB; et al. Cell Host and Microbe. 2021; 29:1744-1756.e5.

Caught in the Hotbox. Sosa, T; Kinnear, B; Choe, AY; Geha, R; Haslam, DB; Weiss, PF; Parker, MW. Journal of hospital medicine (Online). 2021; 16:304-307.

Obeticholic acid ameliorates severity of Clostridioides difficile infection in high fat diet-induced obese mice. Jose, S; Mukherjee, A; Horrigan, O; Setchell, KD R; Zhang, W; Moreno-Fernandez, ME; Andersen, H; Sharma, D; Haslam, DB; Divanovic, S; et al. Mucosal Immunology. 2021; 14:500-510.

From the Blog


Antibiotics Are Not Always the Answer
BlogHealthy Living

Antibiotics Are Not Always the Answer

By David B. Haslam, MD3/2/2018

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey